You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 14, October 8, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Renal Diseases
 •Dialysis
 •Surgery
 •Surgical Interventions
 •Vascular Surgery
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Clopidogrel on Arteriovenous Fistulas for Dialysis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The trial by Dr Dember and colleagues1 failed to show any improvement in fistula maturation for hemodialysis by using clopidrogrel, although its use decreased the frequency of early thrombosis. However, the design of the study might explain some of the results.

Successful arteriovenous fistula creation depends on many important factors. First, there must be adequate predialysis care, particularly protection of the veins from unnecessary cannulations for blood sampling or for intravenous administration of fluids and medications; this was not described. Second, there must be appropriate preoperative evaluation of the arterial and venous networks by methods such as x-rays for possible detection of calcifications of the arteries, Doppler ultrasound for arteries and veins, or venography.2 Although Dember et al report that vascular mapping was performed in almost 75% of the patients,1 they do not provide extensive data. It would be interesting to explore whether mapping presented any advantage, . . . [Full Text of this Article]

Costas Fourtounas, MD, PhD
cfourt@usa.net

Jannis G. Vlachojannis, MD
Department of Internal Medicine–Nephrology
Patras University Hospital
Rio-Patras, Greece



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.